Categories
Business Coronavirus Headlines Marketing News

Herpes Zoster Drug Market to Suffer Slight Decline in 2020, Efforts to Mitigate Coronavirus-related Disruptions Ramp Up

Herpes Zoster Drug Market

A proficient data and brilliant forecasting techniques used in this Herpes Zoster Drug Market report are synonymous with accurateness and correctness. The document is a meticulous analysis of existing scenario of the market, which covers several market dynamics. This market research report endows with the plentiful insights and business solutions that will support to stay ahead of the competition. The most precise way to forecast what future holds is to understand the trend today and hence Herpes Zoster Drug Marketing report has been structured by chewing over numerous fragments of the present and upcoming market scenario.

Get Exclusive Sample Copy of This Report Here https://www.databridgemarketresearch.com/request-a-sample?dbmr=global-herpes-zoster-drug-market

This Herpes Zoster Drug Market report is the consequence of incessant efforts lead by clued-up forecasters, innovative analysts and bright researchers who indulge in detailed and attentive research on different markets, trends and emerging opportunities in the consecutive direction for the business needs. Company snapshot, geographical presence, product portfolio, and recent developments are taken into account for studying the company profiles that are part of this report. Quality and transparency has been strictly maintained while carrying out research studies to offer an exceptional market research report for a niche. A thoughtful knowledge of industrial unanimity, market trends and incredible techniques via this Herpes Zoster Drug Market report gives an upper hand in the market.

Global herpes zoster drug market is growing at a healthy CAGR in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to the increasing exposure to ultraviolet radiation which may suppress the cell-mediated immunity, which is a major factor responsible for the growing incidence of herpes zoster and patients being treated for cancer and affected with advanced HIV infection are at a greater risk of developing herpes zoster, which is expected to boost the growth of the global herpes zoster drug market.

The key market players in the global herpes zoster drug market are GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, Pfizer Inc, Novartis AG, Bristol-Myers Squibb Company, Sanofi, Merck & Co., Inc, Pfizer Inc, AstraZeneca, Abbott, Astellas Pharma Inc, NAL Pharma, TSRL, Inc, GeneOne Life Science, Beijing Minhai Biotechnology Co., Ltd, Foamix Pharmaceuticals Ltd, Maruho Co.,Ltd., Sinovac Biotech Ltd, Hepion Pharmaceuticals, CELGENE CORPORATION and others.

Read Complete Details with TOC Here https://www.databridgemarketresearch.com/toc?dbmr=global-herpes-zoster-drug-market

Market Definition: Global Herpes Zoster Drug Market

Herpes zoster also known as shingles, it is a viral infection, characterized by a painful rashes over the skin, rashes can occur anywhere on the body but it most commonly appears as a single stripe of blisters on the abdomen or backside of the body. Herpes zoster is caused by reactivation of the varicella zoster virus, the same virus that causes chickenpox. Older adults and individuals with weak immune system are at greater risk of having herpes zoster. Signs and symptoms include one-sided stabbing pain, headache, tingling, itching, nausea, body aches, and fluid-filled blistering red rash, typically on the abdomen or face.

According to the Centers for disease control and prevention, US the annual incidence rate of herpes zoster in US population is approximately 4 cases per 1,000 persons. The annual incidence rate among people 60 years of age and older is about 10 cases per 1,000 US populations. There are one million estimated cases of herpes zoster in the United States annually. Increasing exposure of ultraviolet radiation and certain chemical substances which deteriorates the immunity system acts as a major contributing factor for the incidence of herpes zoster.

Segmentation: Global Herpes Zoster Drug Market

Herpes Zoster Drug Market : By Drug

  • Anti-Viral Agents
  • Anti-Inflammatory Agents
  • Analgesics
  • Anticonvulsants Agents
  • Corticosteroids
  • Tricyclic Antidepressants
  • Antihistamines
  • Others

Herpes Zoster Drug Market : By Vaccines

  • Zostavax
  • Shingrix
  • Others

Herpes Zoster Drug Market : By Route of Administration

  • Oral
  • Topical
  • Intravenous
  • Others

Herpes Zoster Drug Market : By Distribution Channel

  • Online Pharmacy
  • Direct Tenders
  • Retailers
  • Others

Herpes Zoster Drug Market : By End Users

  • Hospitals
  • Homecare
  • Specialty Clinics

Herpes Zoster Drug Market : By Geography

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

Key Developments in the Market

  • In May 2019, GlaxoSmithKline plc is developing herpes zoster subunit vaccine (GSK1437173A) for the treatment of herpes zoster (shingles). This vaccine is currently under phase lll clinical trial. It will be indicated for the prevention of herpes zoster (shingles) in adults aged 50 years and older. Currently available vaccines are contraindicated in specific subgroups of people, but this vaccine has a potential to provide long-term immunogenicity to all groups of people
  • In October 2017, GlaxoSmithKline plc received the US FDA approval for Shingrix vaccine for the treatment of herpes zoster. Shingrix is a zoster vaccine recombinant, adjuvanted vaccine against the virus that causes herpes zoster. Shingrix is specifically indicated for the prevention of herpes zoster (shingles) in adults aged 50 years and older and post-herpetic neuralgia (long-lasting nerve pain following shingles)

Opportunities in the Herpes Zoster Drug Market Report :

  1. Comprehensive quantitative analysis of the industry is provided for the period of 20XX-20XX to assist stakeholders to capitalize on the prevailing market opportunities.
  2. Comprehensive analysis of the factors that drive and restrict the market growth is provided in the Herpes Zoster Drug Market report.
  3. Extensive analysis of the key segments of the industry helps in understanding the trends in types of point of care test across regional.
  4. Extensive analysis of the key segments of the industry helps in understanding the trends in types of point of care test across Global.

Want Full Report? Enquire Here @ https://www.databridgemarketresearch.com/inquire-before-buying?dbmr=global-herpes-zoster-drug-market

About Data Bridge Market Research:

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475
Mail: [email protected]